Hepatitis/MASH

Individuals with hepatitis B and hepatitis C may be more susceptible to Parkinson’s disease.

Part 1 of a 4-part interview with an infectious disease expert explores treatment advances in HIV since the AIDS epidemic in the 1980s.

After a prolonged court battle, Abu-Jamal will begin treatment for HCV in prison.

Sovaldi plus Harvoni approved to treat HCV in children ages 12 to 17.

Sovaldi plus Harvoni is the first direct-acting antiviral treatment approved for children and adolescents aged 12 to 17.

The FDA approved supplemental applications for Sovaldi (sofosubuvir) and Harvoni (ledipasvir and sofosbuvir), marketed by Gilead Sciences Inc., to treat hepatitis C virus (HCV) in pediatric patients.

More than 96% of Prime Therapeutics members taking Harvoni cured of hepatitis C virus.

Prime Therapeutics reports more than 94% of patients who completed at last 8 weeks of treatment with Harvoni were cleared of HCV.

An adverse effect with interferon-ribavirin Hepatitis C therapy that does not stop after discontinuation.

Baby Boomer age group testing levels for hepatitis C virus remained very low.

Top news of the day from across the health care landscape.

Need for an increase in HCV testing awareness among health care providers and baby boomers.

Physicians should test for more common liver conditions rather than rare diseases.

Top news of the day from across the health care landscape.

Manufacturers say they are unable to lower the cost of some drugs due to pharmacy benefit manager involvement.

Gilead feuds with Express Scripts over hepatitis C virus drug costs.

Up to 30% of people who have HIV, and more than 80% of HIV-positive injection drug users also have hepatitis C virus (HCV) as well.

Cannabidiol found in cannabis could be used as a novel treatment for hepatitis C virus

Cannabidiol was overserved to elicit antiviral properties against HCV.

The Iowa Department of Public Health released its first report on hepatitis C virus.

Flawed patents challenged on blockbuster HCV drugs to allow generic production.

Assay quantitates HCV viral load and confirms active HCV infection.

Research indicates hepatitis C virus is linked to cancers other than hepatocellular carcinoma and non-Hodgkin lymphoma.

New findings suggest that hepatitis C may cause cancers other than hepatocellular carcinoma and non-Hodgkin lymphoma.

Top articles of the week on Specialty Pharmacy Times.